Genetics of ischaemic stroke; single gene disorders

International Journal of Stroke

Volumn 1, Issue 3, 2006, Pages 131-139

  Flossmann, Enrico ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

CAOASIL; Genetic disorders; Ischaemic stroke; MELAS

Indexed keywords

ARGININE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA1 CHAIN; DICHLOROACETIC ACID; FIBRILLIN 1; NEUROFIBROMIN; NOTCH3 RECEPTOR; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ARTERY DISSECTION; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CADASIL; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CHROMOSOME 19Q; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSLIPIDEMIA; FABRY DISEASE; FAMILIAL DISEASE; FAMILY HISTORY; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC SCREENING; HEALTH HAZARD; HEART ARRHYTHMIA; HEART ATRIUM MYXOMA; HEMOGLOBIN SC DISEASE; HEREDITY; HOMOCYSTINURIA; HOMOZYGOSITY; HUMAN; LACTIC ACIDOSIS; LEUKOENCEPHALOPATHY; LONG QT SYNDROME; MARFAN SYNDROME; MELAS SYNDROME; NEUROFIBROMATOSIS; NONHUMAN; ONSET AGE; OSTEOGENESIS IMPERFECTA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; SMOKING; STROKE; THALASSEMIA; THROMBOGENESIS; THROMBOPHILIA; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

BRAIN ISCHEMIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; STROKE;

EID: 33746585808     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2006.00037.x     Document Type: Review

References (81)

1. Hassan A, Markus HS: Genetics and ischaemic stroke. Brain 2000; 123: 1784-812.
2. Munke M, Kraus JP, Ohura T, Francke U.: The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. Am J Hum Genet 1988; 42: 550-9.
3. Kraus JP.: Komrower lecture. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis 1994; 17: 383-90.
4. Sebastio G, Sperandeo MP, Panico M, Kraus JP, Andria G.: The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995; 56: 1324-33.
5. Mudd SH, Skovby F, Levy HL et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985; 37: 1-31.
6. Kelly PJ, Furie KL, Kistler JP et al. Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology 2003; 60: 275-9.
7. Brown MS, Goldstein JL, Fredrickson DS.: Familial type 3 hyperlipoproteinemia; in Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein RJ, Brown MS (eds): The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1983: 655-71.
8. Natowicz M, Kelley RI.: Mendelian etiologies of stroke. Ann Neurol 1987; 22: 175-92.
9. Third JL, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ.: Primary and familial hypoalphalipoproteinemia. Metabolism 1984; 33: 136-46.
10. Kontusaari S, Tromp G, Kuivaniemi H, Romanic AM, Prockop DJ.: A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms. J Clin Invest 1990; 86: 1465-73.
11. Kontusaari S, Tromp G, Kuivaniemi H, Ladda RL, Prockop DJ.: Inheritance of an RNA splicing mutation (G+1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotypic overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV. Am J Hum Genet 1990; 47: 112-20.
12. Lee B, Vitale E, Superti-Furga A, Steinmann B, Ramirez F.: G to T transversion at position +5 of a splice donor site causes skipping of the preceding exon in the type III procollagen transcripts of a patient with Ehlers-Danlos syndrome type IV. J Biol Chem 1991; 266: 5256-9.
13. Boileau C, Jondeau G, Mizuguchi T, Matsumoto N.: Molecular genetics of Marfan syndrome. Curr Opin Cardiol 2005; 20: 194-200.
14. Marchuk DA, Saulino AM, Tavakkol R et al. cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product. Genomics 1991; 11: 931-40.
15. Barsh GS, David KE, Byers AH.: Type I osteogenesis imperfecta: a nonfunctional allele for proalpha 1(I) chains of type I procollagen. Proc Natl Acad Sci 1982; 79: 3838-42.
16. van Bogaert L.: Encephalopathie sous-corticale progressive (Binswanger) évolution rapide chez deux soeurs. Med Hellen 1955; 24: 961-72.
17. Sourander P, Walinder J.: Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol (Berlin) 1977; 39: 247-54.
18. Stevens DL, Hewlett RH, Brownell B.: Chronic familial vascular encephalopathy. The Lancet 1977; 1: 1364-5.
19. Colmant HJ.: Familiäre zerebrale Gefäβerkrankung. Zbl Allgemein Pathologie 1980; 124: 163.
20. Davous P, Fallet-Bianco C.: Familial subcortical dementia with arteriopathic leukoencephalopathy. A clinico-pathological case. Rev Neurol (Paris) 1991; 147: 376-84.
21. Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG.: Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991; 22: 1297-302.
22. Kalaria RN, Viitanen M, Kalimo H, Dichgans M, Tabira T.: The pathogenesis of CADASIL: An update. J Neurol Sci 2004; 226: 35-9.
23. Razvi SS, Davidson R, Bone I, Muir KW.: The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 2005; 76: 739-41.
24. Tournier-Lasserve E, Joutel A, Melki J et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993; 3: 256-9.
25. Joutel A, Bousser MG, Biousse V et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993; 5: 40-5.
26. Joutel A, Corpechot C, Ducros A et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383: 707-10.
27. Dichgans M, Mayer M, Müller-Myhsok B, Straube A, Gasser T.: Identification of a key recombinant narrows the CADASIL gene region to 8 cM and argues against allelism of CADASIL and familial hemiplegic migraine. Genomics 1996; 32: 151-4.
28. Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87: 543-52.
29. Levitan D, Greenwald I: Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377: 351-4.
30. Dubroca C, Lacombe P, Domenga V et al. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke 2005; 36: 113-7.
31. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A.: Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke 2005; 36: 1053-8.
32. Bianchi S, Dotti MT, Federico A: Physiology and pathology of notch signalling system. J Cell Physiol 2006; 207: 300-8.
33. Joutel A, Vahedi K, Corpechot C et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. The Lancet 1997; 350: 1511-5.
34. Joutel A, Dodick DD, Parisi JE, Cecillon M, Tournier-Lasserve E, Bousser MG.: De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol 2000; 47: 388-91.
35. Tuominen S, Juvonen V, Amberla K et al. Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation. Stroke 2001; 32: 1767-74.
36. Choi EJ, Choi CG, Kim JS: Large cerebral artery involvement in CADASIL. Neurology 2005; 65: 1322-4.
37. Dichgans M: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: Phenotypic and mutational spectrum. J Neurol Sci 2002; 203-204: 77-80.
38. Singhal S, Bevan S, Barrick T, Rich P, Markus HS.: The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004; 127: 2031-8.
39. Rufa A, Dotti MT, Franchi M et al. Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2005; 36: 2554-8.
40. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS.: MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001; 56: 628-34.
41. Dichgans M, Filippi M, Bruning R et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 1999; 52: 1361.
42. Cumurciuc R, Guichard JP, Reizine D, Gray F, Bousser MG, Chabriat H.: Dilation of Virchow-Robin spaces in CADASIL. Eur J Neurol 2006; 13: 187-90.
43. Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA.: Cerebral microbleeds iA CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke 2002; 33: 67-71.
44. Lesnik Oberstein SAJ, van den Boom R, van Buchem MA et al. Cerebral microbleeds in CADASIL. Neurology 2001; 57: 1066-70.
45. van den Boom R, Lesnik Oberstein SAJ, Ferrari MD, Haan J, van Buchem MA.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and Leukoencephalopathy: MR imaging findings at different ages -3rd-6th decades. Radiology 2003; 229: 683-90.
46. Ebke M, Dichgans M, Bergmann M et al. CADASIL: Skin biopsy allows diagnosis in early stages. Acta Neurol Scand 1997; 95: 351-7.
47. Rolfs A, Böttcher T, Zschiesche M et al. Prevalence of Fabry disease in patients with cryptogenic stroke: A prospective study. The Lancet 2005; 366: 1794-6.
48. Vidal R, Frangione B, Rostagno A et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999; 399: 776-81.
49. Gould DB, Phalan FC, van Mil SE et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006; 354: 1489-96.
50. Verreault S, Joutel A, Riant F et al. A novel hereditary small vessel disease of the brain. Ann Neurol 2006; 59: 353-7.
51. Yanagawa S, Ito N, Arima K, Ikeda Si.: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology 2002; 58: 817-20.
52. Jen J, Cohen AH, Yue Q et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997; 49: 1322-30.
53. Franz WM, MuFler OJ, Katus HA: Cardiomyopathies: from genetics to the prospect of treatment. Lancet 2001; 358: 1627-37.
54. Viskin S: Long QT syndromes and torsade de pointes. Lancet 1999; 354: 1625-33.
55. Brugada R, Tapscott T, Czernuszewicz GZ et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336: 905-11.
56. Chen YH, Xu SJ, Bendahhou S et al. KCNQ1 Gain of function mutation in familial atrial fibrillation. Science 2003; 299: 251-4.
57. Yang Y, Xia M, Jin Q et al. Identification of a KCNE2 gain of function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75: 899-905.
58. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA.: Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 2003; 107: 2880-3.
59. Gilon D, Buonanno FS, Joffe MM et al. Lack of evidence of an association between Mitral-Valve Prolapse and stroke in young patients. N Engl J Med 1999; 341: 8-13.
60. Carney JA: Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol 1985; 9: 53-5.
61. Narita H, Odawara T, Matsumoto T et al. A case with late-onset MELAS with hallucination and delusion. No To Shinkei 2004; 56: 345-9.
62. Koo B, Becker LE, Chuang S et al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): Clinical, radiological, pathological, and genetic observations. Ann Neurol 1993; 34: 25-32.
63. Ciafaloni E, Ricci E, Shanske S et al. MELAS: Clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 391-8.
64. Matthews PM, Tampieri D, Berkovic SF et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991; 41: 1043-6.
65. Hasuo K, Tamura S, Yasumori K et al. Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes); report of 3 cases. Neuroradiology 1987; 29: 393-7.
66. Morita K, Ono S, Fukunaga M et al. Increased accumulation of n-isopropyl-p-(123I)-iodoamphetamine in two cases with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). Neuroradiology 1989; 31: 358-61.
67. Forster C, Hubner G, Muller-Hocker J et al. Mitochondrial angiopathy in a family with MELAS. Neuropediatrics 1992; 23: 165-8.
68. Gropen TI, Prohovnik I, Tatemichi TK, Hirano M.: Cerebral hyperemia in MELAS. Stroke 1994; 25: 1873-6.
69. Goto Yi, Nonaka I, Horai S.: A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
70. Majamaa K, Turkka J, Karppa M, Winqvist S, Hassinen IE.: The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct. Neurology 1997; 49: 1331-4.
71. diMauro S.: Mitochondrial diseases. Biochim Biophys Acta 2004; 1658: 80-8.
72. Kaufmann P, Shungu DC, Sano MC et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004; 62: 1297-302.
73. Kaufmann P, Engelstad K, Wei Y et al. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology 2006; 66: 324-30.
74. Koga Y, Akita Y, Nishioka J et al. l-Arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005; 64: 710-2.
75. Schwartz M, Vissing J: Paternal inheritance of mitochondrial DNA. N Engl J Med 2002; 347: 576-80.
76. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR: Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-6.
77. Fabian RH, Peters BH: Neurological complications of hemoglobin SC disease. Arch Neurol 1984; 41: 289-92.
78. Aessopos A, Farmakis D, Karagiorga M, Rombos I, Loucopoulos D: Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in beta-thalassemia patients. Stroke 1997; 28: 2421-4.
79. Markus HS, Hambley H: Neurology and the blood: haematological abnormalities in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998; 64: 150-9.
80. Mackie IJ, Colaco CB, Machin SJ: Familial lupus anticoagulants. Br J Haematol 1987; 67: 359-63.
81. Pettee AD, Wasserman BA, Adams NL et al. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers. Neurology 1994; 44: 399-405.